ARCHIVES

CCOPs Favor Ability To Enter Patients On Any Group Study

This article is from The Cancer Letter archive.

Vol. 24 No. 23 | June 12, 1998

Download PDF Visit The Full Archive

Related Articles

NIH reiterates Position On Closed Meeting Of BSC Chairmen

September 23, 1994

How ImClone’s “Hot” New Drug Got Cold Shoulder From FDA

March 8, 2002

NCI Cooperative Group, Cancer Center Trials Listed

January 30, 2009

OSI “Front Line Office” In Probes Of Scientific Misconduct, Kimes Tells NCAB

October 13, 1989

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007

In Brief: An Era Ends – Lee Clark Retires After 32 Years As Head Of UT Center; Lemaistre Succeeds Him

August 4, 1978